| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Mirna Therapeutics, Inc. | 150,000 | 656,000 | 0.05% | ||
| 2 | PORTOLA PHARMACEUTICALS INC | 35,000 | 714,000 | 0.06% | Call | |
| 3 | BLUEBIRD BIO INC COM | 20,000 | 850,000 | 0.07% | ||
| 4 | WRIGHT MED GROUP INC SR CONV NT 2 20 | 1,000,000 | 898,000 | 0.08% | PRN | |
| 5 | SOPHIRIS BIO INC | 628,563 | 905,000 | 0.08% | ||
| 6 | PUMA BIOTECHNOLOGY | 31,500 | 925,000 | 0.08% | ||
| 7 | OREXIGEN THERAPEUTICS INC COM | 1,653,000 | 930,000 | 0.08% | ||
| 8 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 78,000 | 1,237,000 | 0.10% | ||
| 9 | INTERCEPT PHARMACEUTICALS INCORPORATED | 10,000 | 1,285,000 | 0.11% | ||
| 10 | INFINITY PHARMACEUTICALS INC | 270,000 | 1,423,000 | 0.12% | ||
| 11 | ANTHERA PHARMACEUTICALS I | 450,000 | 1,629,000 | 0.14% | ||
| 12 | CERULEAN PHARMA INC | 625,000 | 1,694,000 | 0.14% | ||
| 13 | Life Technologies Corp | 433,496 | 1,708,000 | 0.14% | ||
| 14 | TETRAPHASE PHARMACEUTICALS INC COM | 400,000 | 1,852,000 | 0.16% | ||
| 15 | ASSEMBLY BIOSCIENCES INC | 390,000 | 1,958,000 | 0.16% | ||
| 16 | Nivalis Therapeutics Inc | 489,000 | 2,039,000 | 0.17% | ||
| 17 | Egalet Corp | 300,000 | 2,058,000 | 0.17% | ||
| 18 | DIMENSION THERAPEUTICS INC | 271,370 | 2,125,000 | 0.18% | ||
| 19 | OPHTHOTECH CORP | 51,500 | 2,177,000 | 0.18% | ||
| 20 | VALEANT PHARMACEUTICALS INTL | 85,500 | 2,249,000 | 0.19% | ||
| 21 | DBV TECHNOLOGIES S A | 73,000 | 2,376,000 | 0.20% | ||
| 22 | ALDER BIOPHARMACEUTICALS INC | 97,500 | 2,388,000 | 0.20% | ||
| 23 | CLOVIS ONCOLOGY INC | 125,000 | 2,400,000 | 0.20% | ||
| 24 | SAREPTA THERAPEUTICS INC | 131,000 | 2,557,000 | 0.21% | ||
| 25 | SCYNEXIS INC | 635,000 | 2,559,000 | 0.21% | ||
| 26 | AURIS MED HLDG AG | 787,600 | 2,867,000 | 0.24% | ||
| 27 | RIGEL PHARMACEUTICAL INC | 1,464,050 | 3,045,000 | 0.26% | ||
| 28 | ENDOCHOICE HLDGS INC | 590,000 | 3,074,000 | 0.26% | ||
| 29 | NOVOCURE LTD | 214,316 | 3,103,000 | 0.26% | ||
| 30 | CIDARA THERAPEUTICS INC | 250,000 | 3,175,000 | 0.27% | ||
| 31 | DYNAVAX TECHNOLOGIES CORP | 165,000 | 3,175,000 | 0.27% | ||
| 32 | PARATEK PHARMACEUTICALS INC | 223,000 | 3,383,000 | 0.28% | ||
| 33 | MEDICINES CO SR GLBL CV NT 22 | 3,000,000 | 3,405,000 | 0.29% | PRN | |
| 34 | ADR - Nabriva Therapeutics AG- Usd | 380,000 | 3,405,000 | 0.29% | ||
| 35 | PORTOLA PHARMACEUTICALS INC | 175,000 | 3,570,000 | 0.30% | ||
| 36 | Otonomy Inc | 240,000 | 3,581,000 | 0.30% | ||
| 37 | KITE PHARMA INCORPORATED | 80,000 | 3,673,000 | 0.31% | ||
| 38 | GENOCEA BIOSCIENCES INC | 480,000 | 3,715,000 | 0.31% | ||
| 39 | PERRIGO CO PLC | 30,000 | 3,838,000 | 0.32% | ||
| 40 | AVEXIS INC COM | 142,758 | 3,889,000 | 0.33% | ||
| 41 | AIMMUNE THERAPEUTICS INC COM | 293,000 | 3,973,000 | 0.33% | ||
| 42 | MACROGENICS INC | 225,000 | 4,219,000 | 0.35% | ||
| 43 | FIBROGEN INC | 204,000 | 4,343,000 | 0.36% | ||
| 44 | NOVAVAX INC COM | 852,500 | 4,399,000 | 0.37% | ||
| 45 | CHIASMA INC | 492,500 | 4,511,000 | 0.38% | ||
| 46 | PROTEOSTASIS THERAPEUTICS IN COM | 470,000 | 4,531,000 | 0.38% | ||
| 47 | COMPUGEN LTD | 820,000 | 4,576,000 | 0.38% | ||
| 48 | ALLERGAN PLC | 5,000 | 4,585,000 | 0.38% | ||
| 49 | CARDIOME PHARMA CORP | 1,190,000 | 4,867,000 | 0.41% | ||
| 50 | TANDEM DIABETES CARE INC COM | 562,500 | 4,899,000 | 0.41% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003409, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
